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Abstract The binding epitope structure of a protein
specifically recognized by an antibody provides key
information to prevent and treat diseases with therapeutic
antibodies and to develop antibody-based diagnostics.
Epitope structures of antigens can be effectively identified
by the proteolytic epitope excision–mass spectrometry
(MS) method, which involves (1) immobilization of
monoclonal or polyclonal antibodies, e.g., on N-hydrox-
ysuccinimide-activated sepharose, (2) affinity binding of
the antigen followed by limited proteolytic digestion of the
immobilized immune complex, and (3) elution and mass
spectrometric analysis of the remaining affinity-bound
peptide(s). In the epitope analysis of recombinant cellular
bovine prion protein (bPrPC) to a monoclonal antibody
(mAb3E7), we found that epitope excision experiments
resulted in extensive nonspecific binding of bPrP to a
standard sepharose matrix employed. Here, we show that
the use of amino-modified polystyrene beads with aldehyde
functionality is an efficient alternative support for antibody
immobilization, suitable for epitope excision–MS, with
complete suppression of nonspecific bPrP binding.
Keywords Epitope excision . Polystyrene beads . Prion
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Introduction
Aggregated amyloid-like proteins are involved in neurode-
generative diseases such as Parkinson's, Alzheimer's,
Creutzfeldt-Jacob, and prion disorders. These diseases are
believed to be caused by structural and/or conformational
changes in proteins, leading to protein aggregation and
finally to amyloid-like fibril formation [1, 2]. Prion diseases
belong to the transmissible spongiform encephalopathies
disease class and have been found both in humans and
animals [3]. Fundamental insights into the mechanisms of
these diseases are of paramount importance for the develop-
ment of both diagnostic and effective therapeutic approaches.
Structural information on antigen–antibody interactions,
particularly on antigen epitopes, is essential for the develop-
ment of new diagnostics and for molecular vaccine design. A
number of methods have been developed and are currently
employed for the determination of antigen epitopes [4]. For
example, a widely used epitope mapping technique is based
on competition between overlapping synthetic peptides or
subunits of recombinant peptide fragments and the complete
antigen sequence for the antibody binding site. Major
limitations of such techniques are that (1) they are only
suitable for determination of linear epitope sequences, (2)
partial sequences may fail to represent a complete recogni-
tion sequence, and (3) they are not suitable for identification
of discontinuous epitopes, a type to which many epitopes
belong [5]. High-resolution structural information of inter-
acting residues of an antigen and an antibody can be
obtained by X-ray crystallography and nuclear magnetic
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resonance (NMR) spectroscopy [6]. However, these methods
require high amounts of sample and a long time for analysis
[7, 8]. Moreover, many protein complexes cannot be
crystallized for structure determination, and NMR methods
are strongly limited by available sample amounts, solubility
issues, and the size of the proteins, which is particularly
restrictive in the case of antigen–antibody complexes.
Epitope mapping approaches based on mass spectrom-
etry have several advantages due to the molecular informa-
tion obtained, high mass accuracy, short analysis time,
sensitivity, and low sample consumption for the determi-
nation of linear, as well as discontinuous epitopes [6]. The
proteolytic epitope excision–mass spectrometry approach
[9] has been developed as a powerful method to directly
identify amino acid sequences on an antigen involved in
antigen–antibody interaction; this method involves limited
proteolysis of the immune complex formed [10]. Anti-
bodies are generally highly resistant towards proteolytic
digestion and at the same time they protect the binding
region on an antigen from possible cleavage by shielding.
This approach has been successfully applied for epitope
determinations on many peptide and protein antigens
recognized by monoclonal as well as polyclonal antibodies
[11–18]. Also, an antibody paratope has recently been
identified using this technique [19]. However, when we
applied this method for epitope excision on bovine prion
protein (bPrP), abundant unspecific binding of bPrP to the
sepharose material, most commonly used for antibody
immobilization, was observed. Sepharose is a porous support
material widely used for affinity chromatography that can
“bury” protein molecules and therefore may lead to
unspecific binding, in addition to specific binding to the
antibody. The unspecific binding may be pronounced in the
case of hydrophobic amyloid-like structures such as bPrP,
which is known to readily aggregate.
Here, we present a high-efficiency epitope excision
method for bPrP, by immobilizing the antibody on amino-
modified polystyrene (PS) beads. The PS particles are
frequently used as carriers of biomolecules in biomedical
applications, mainly in immunoassays [20–22]. This ap-
proach showed a significant improvement of the epitope
peptide identification from bPrP(25-241), recognized by the
monoclonal antibody 3E7. Furthermore, the washing and
elution steps were automated by centrifuging the beads
using centrifugal filter units.
Experimental
Materials
Recombinant cellular bovine prion protein (bPrPC) buffered
in 10 mM sodium acetate at pH 4.0 and monoclonal anti-
bPrP antibody mAb3E7 buffered in phosphate saline buffer
(PBS) at pH 7.4 were obtained from Roboscreen (Leipzig,
Germany). N-hydroxysuccinimide (NHS)-activated sephar-
ose 4B was purchased from Sigma-Aldrich Chemie GmbH
(Buchs SG, Switzerland). Amino-modified PS beads with a
diameter of 0.65 μm were obtained from Bangs Laborato-
ries Inc. (Fishers, IN, USA). “Mobicol” columns for affinity
chromatography with a volume of 1 ml were obtained from
MoBiTec GmbH (Göttingen, Germany). Centrifugal filter
units with a molecular weight cutoff (MWCO) of 50 kDa
“Microcon YM-50” and ZipTip C18 desalting pipette tips
were obtained from Millipore (Billerica, MA, USA).
Sequencing-grade chymotrypsin was purchased from
Roche Diagnostics GmbH (Penzberg, Germany). C18
material for nano-LC-columns, Magic 3 μm 200 Å C18
AQ, was obtained from Bischoff GmbH (Leonberg,
Germany).
Antibody immobilization on sepharose
Dry NHS-activated sepharose, 60 mg, was vigorously
mixed with 200 μl of coupling buffer (0.2 M NaHCO3,
0.5 M NaCl in ultrapure H2O at pH 8.3) containing 100 μg
of mAb3E7 in a reaction tube for 2 h at room temperature.
Covalent attachment of antibodies to the sepharose was
achieved through primary amino groups of their N termini
and lysine residues. The reaction mixture, mAb3E7 coupled
to sepharose, was loaded into a “Mobicol” microcolumn.
Unbound mAb3E7 was removed, and the remaining free
primary amine groups on the sepharose were deactivated by
subsequent washing of the column with 12 ml of blocking
buffer (0.1 M ethanolamine, 0.5 M NaCl in ultrapure H2O
at pH 8.3) and 12 ml of washing buffer (0.2 M CH3CO2Na,
0.5 M NaCl in ultrapure H2O at pH 4.0) using a syringe.
The blocking–washing procedure was repeated seven times,
and after the fourth time, the column was incubated for 1 h
in blocking buffer followed by the washing step. After-
wards, the column was washed two times with 12 ml of
PBS buffer (5 mM Na2HPO4, 150 mM NaCl in ultra pure
H2O at pH 7.5) and stored at 4 °C until further use. In the
control experiments without mAb3E7, the procedure was
exactly the same but no antibody was added to the coupling
buffer.
Analysis of bPrP/mAb3E7 affinity
Following the mAb3E7 immobilization on sepharose,
10 μg of rec-bPrPC (5 μl of a 2 μg/μl protein solution)
was diluted with 50 μl of PBS buffer at pH 7.5 in order to
increase the pH of the protein solution and then added to
the column. The mixture was incubated at room tempera-
ture for 2 h in PBS buffer with gentle shaking. The fraction
of unbound bPrP was collected for further analysis by
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sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE). Unbound bPrP was washed five times with
12 ml of PBS buffer and one time with ultrapure water. In
order to control the efficiency of the washing step, the
final aliquots of about 1 ml after both washings were
collected. The bPrP-bound specifically to the mAb3E7
was eluted two times from the affinity medium with
500 μl of 0.1% trifluoroacetic acid (TFA) while gently
shaking for 15 min. The collected fractions were lyoph-
ilized and then dissolved in 30–50 μl of loading buffer for
SDS-PAGE analysis, which was carried out on a 12% gel
according to Laemmli’s method [23]. Protein samples
were loaded on the gel at the volume of 15–20 μl. For
molecular weight calibration, a commercial protein mix-
ture in the range of 15–150 kDa was used. Proteins were
visualized by silver staining [24].
Antibody immobilization on polystyrene beads
Immobilization of mAb3E7 on NH2-activated PS beads and
epitope excision were carried out in a 50-kDa MWCO
Microcon centrifugal filter unit (0.5 ml). A “Mobicol”
column was placed on the top of a filter in order to increase
the volume (1 ml). The buffers used had the same
composition as in the experiments on the sepharose
column. First, 60 mg of beads was washed two times with
600 μl of washing buffer. Then, the beads were incubated
with 10% solution of glutaraldehyde in washing buffer
while gently mixing for 2 h at room temperature according
to Bangs Lab’s user guide in order to introduce a chemical
spacer between the matrix and the antibody to avoid steric
hindrance and therefore to maximize antibody binding. The
beads were washed three times with 600 μl of washing
buffer and three times with 600 μl of coupling buffer. All
washing steps were conducted as follows: 600 μl of buffer
was added to the beads in the Microcon centrifugal filter
unit, mixed for 2 min and centrifuged at 7,500 rpm for
about 5 min until the initial volume was re-established.
Antibody, 100 μg of mAb3E7 in coupling buffer, was
added as described for antibody immobilization on sephar-
ose. Blocking of free amine groups and washing steps were
carried out in the similar way as described for the sepharose
experiment with difference in the applied volumes and use
of centrifugation.
Epitope excision
Affinity binding of rec-bPrPC to the immobilized mAb3E7
on sepharose or on PS beads was carried out in a similar
way: 10 μg of rec-bPrPC in 50 μl of PBS buffer was added
to the mAb3E7-immobilized column in the case of
sepharose or to the mAb3E7-immobilized centrifugal filter
unit in the case of PS beads. The mixture was incubated at
room temperature for 2 h with gentle shaking. Afterwards,
unbound bPrP was removed by washing five times with
12 ml of PBS buffer in the case of a sepharose column and
ten times with 600 μl of PBS buffer in the case of a beads
column.
Sequencing-grade chymotrypsin dissolved in PBS buffer
was added to the affinity-bound bPrP/mAb3E7 complex
formed to give an enzyme to bPrP protein ratio of 1:20
(w/w). Proteolysis was carried out at 25 °C overnight. After
digestion, the sepharose column was washed ten times with
12 ml of PBS buffer and three times with 12 ml of ultrapure
water to remove the proteolytic products. The centrifugal
filter unit with beads was washed five times with 600 μl of
PBS buffer and five times with 600 μl of ultrapure water.
The first 1 ml of the digest (supernatant) and the last 1 ml
of the washing fraction with water (“wash”) were collected
in order to control both the digestion and washing steps.
The bPrP fragments that were protected from chymotryptic
proteolysis by mAb3E7 were then eluted two times with
500 μl of 0.1% TFA (“elution”) while gently shaking for
15 min. The collected fractions were lyophilized and later
dissolved in 10 μl of 0.1% TFA for further analysis by nano
liquid chromatography–electrospray ionization Fourier
transform ion cyclotron resonance mass spectrometry
(nano-LC–ESI–FTICR MS).
Nano-LC–ESI–FTICR mass spectrometry
The peptides generated by proteolytic digestion were
separated in a nano high-performance liquid chromatogra-
phy (nano-HPLC) system (Eksigent Technologies, Dublin,
CA, USA) using self-made reversed-phase columns packed
with C18 material. ESI–FTICR MS analysis was carried out
on a commercial FTICR mass spectrometer (LTQ-FTMS,
Thermo Finnigan, Bremen, Germany) coupled to the nano-
HPLC. This technique is very sensitive, allowing attomole
detection and providing high resolution and mass accuracy
necessary for unambiguous identification of the resulting
peptides. Before analysis, every sample was cleaned up
with ZipTip C18 pipette tips (Millipore) according to the
manual of the manufacturer. Ions in the mass-to-charge
range (m/z) from 300 to 2,000 Da were acquired, and MS/
MS data were collected using collision-induced dissocia-
tion (CID). Low-energy CID of the peptides was con-
ducted in the ion trap. Conditions for MS/MS acquisitions
were as follows: normalized collision energy, 35%; ion
selection threshold, 500 counts; activation q=0.25; and
activation time 30 ms. Target ions already selected for
MS/MS were dynamically excluded for 60 s.
Peptide assignment was achieved using the MS/MS
ion search option of MASCOT (Matrix Science Inc.,
Boston, MA, USA) search engine and the SwissProt
database. A mass tolerance of ±5 ppm for peptide
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precursor ions and of ±0.6 Da for MS/MS fragments was
used for peptide identification, allowing up to three
missed cleavages. The absolute peak intensities averaged
over the elution time of each of the identified bPrP
peptides were extracted manually from each LC–MS run
using the “extracted ion chromatogram” option of
XCalibur 2.0 (Thermo Finnigan, Bremen, Germany),
the instrument-specific software. Peak intensities below
500 a.u. were considered as a noise.
Results and discussion
The epitope excision–MS approach was applied to first
verify the linear epitope on bPrP(25-241) recognized by
mAb3E7, which has been determined earlier in our group
as peptide [150–160] by an indirect approach combining
chemical cross-linking with mass spectrometry [25]. The
epitope excision method was chosen because “native-like”
environment can be used to preserve the conformation of
both proteins and thus allow the affinity interaction of an
antigen with its antibody. Conditions for proteolytic diges-
tion of bPrP(25-241) in the absence of the antibody have
been previously optimized [25] and used in the following
experimental procedures. Chymotrypsin was the enzyme
of choice here, as it generates peptides in the appropriate
size and mass range for identification by LC–ESI–FTICR
MS, resulting in a higher sequence coverage of bPrP
compared to tryptic digestion. The greater part of bPrP(25-
241) was completely digested at the conditions employed.
This was monitored by SDS-PAGE, by comparing gel
bands which corresponded to aliquots of digested bPrP
after 2, 4, 6 h and overnight with a gel band of undigested
bPrP at about 24 kDa (data not shown). The conditions of
chymotryptic digestion were deemed appropriate when no
gel band was observed at 24 kDa and when resulting
peptides were identified unambiguously by LC–ESI–
FTICR MS.
In the epitope excision experiments, the antibody was
first immobilized on NHS-activated sepharose, which is a
macroporous chromatography matrix with a high chemical
and physical stability. NHS activation of sepharose is
Fig. 1 a Chemical structure of sepharose and b scheme of derivatization of N-hydroxy-succinimide (NHS)-activated surface on sepharose. c
Schematic representation of antibody immobilization on NH2-activated PS beads using glutaraldehyde as a spacer
Fig. 2 Silver-stained 12% SDS-PAGE demonstrates the affinity
between the immobilized mAb3E7 and the bPrP(25-241). Molecular
weight markers (in kilodalton) are shown on the left side of the gel,
and each line is labeled according to the sample applied. The major
gel band corresponds to bPrP, which was detected following elution
by acidification of bPrP/mAb3E7 complex. Washing fractions before
elution were also analyzed (lanes 3 and 4), and they show no unbound
bPrP in the affinity medium
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schematically shown in Fig. 1a, b where hydroxyl groups of
the sugar residues are used for modification. The antigen,
bPrP(25-241), whose amino acid sequence is given in
Fig. 3a, was added to the microcolumn. The affinity
between the immobilized mAb3E7 and the bPrP was
confirmed by SDS-PAGE (Fig. 2). The most abundant gel
band corresponds to bPrP, which was eluted from the
antibody with 0.1% TFA, although it was not as intense as
expected. A small part of unbound bPrP was left after
incubation of mAb3E7 and bPrP, as displayed on the gel.
This suggests that the amount of bPrP added to the
mAb3E7-immobilized column was sufficient, and most
probably both specific interaction of bPrP with the
antibody and unspecific binding with sepharose took
place.
Chymotryptic epitope excision was conducted as de-
scribed in the experimental part. Following the collection of
bPrP peptides after proteolysis (supernatant), the micro-
column was extensively washed with PBS buffer, and the
last fractions were analyzed by LC–ESI–FTICR MS until
bPrP(25-241)
a
b
c
Fig. 3 a Amino acid sequence
of bPrP(25-241). b, c Diagrams
displaying the mean values with
the standard error of the mean of
the absolute peak intensities for
each of the identified bPrP(25-
241) peptide in the supernatant
(gray bars) and in the elution
fractions (black bars), shown on
a logarithmic scale. The data
were obtained from three inde-
pendent experiments on chymo-
tryptic epitope excision–mass
spectrometry on a sepharose
column b with immobilized
mAb3E7 and c without the
antibody immobilized. There
were no bPrP peptides detected
in the washing fraction before
elution. Each peptide was iden-
tified at least in two experiments
and depicted with its numbers
assigned corresponding to the
position in the bPrP sequence
and with its charge state. Signal
intensities below 500 arbitrary
units were considered as noise
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bPrP peptides were no longer detected. The bPrP fragments
constituting the epitope were eluted from the affinity
medium by acidification. The data summarized in Fig. 3b
display the mean values with the standard error of the mean
of absolute peak intensities extracted from LC–MS runs of
each of the identified bPrP peptides presented in the
supernatant (gray bars) and in the elution (black bars)
fractions from three independent experiments. The peptides
identified are almost the same in both fractions and among
them the known epitope peptide [150–160], although the
elution fraction was expected to contain only epitope
specific peptide(s). A strong reduction in the peak intensi-
ties of the eluting peptides was also observed, possibly due
to dilution of the bPrP peptides by the extensive washing
steps before elution. These results indicate significant
nonspecific binding of bPrP to the sepharose matrix,
suggesting that epitope identification would be difficult at
these conditions.
To verify nonspecific binding, we conducted experi-
ments following the same protocol but in the absence of
antibody in the coupling buffer. We found the same bPrP
peptides in the supernatant as in the experiments with
mAb3E7, corresponding to 67% of the bPrP(25-241)
sequence (Fig. 3c) and at the comparable peak intensities.
This indicates that quite significant nonspecific binding
with sepharose material occurred. While the open-pore
structure of sepharose ensures high-capacity binding for
large biomolecules such as antibodies, it may lead to
unspecific binding, e.g., of the highly hydrophobic peptides
produced by digestion of bPrP(25-241).
Antibodies can also be immobilized on PS beads, a
procedure which is often used in biomedical diagnostics
[20, 21]. Here, we introduce NH2-activated PS beads as an
alternative matrix for epitope excision. PS beads represent a
nonporous immobilization support for antibodies and we
reasoned that antigen molecules would stick less to the
bead surface. In order to avoid “steric crowding” when
coupling antibody molecules and to facilitate effective
binding of an antigen to the antibody, a glutaraldehyde
spacer was introduced between the beads matrix and an
PS-beads column with mAb3E7
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Fig. 4 Sections of LC–ESI–FTICR mass spectra derived from
extracted ion chromatograms for each of identified bPrP(25-241)
peptides with their m/z values and charge states a in the supernatant
and b in the elution fractions, obtained from chymotryptic epitope
excision on PS beads affinity column with immobilized mAb3E7.
There were no bPrP peptides detected in the washing fraction before
elution
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antibody, as depicted in Fig. 1c. Covalent attachment of
mAbs takes place through reaction between the surface
aldehyde groups of the PS beads and the amino groups of
lysines and N terminus.
To investigate nonspecific binding effects of bPrP(25-
241) to the PS bead matrix modified with glutaraldehyde, a
control proteolytic experiment without antibody mAb3E7
was conducted as described in the experimental part. No
bPrP peptides were detected, neither in the supernatant nor
in the elution fraction, demonstrating the absence of
nonspecific adsorption. This is probably due to the much
smaller specific surface of the beads. The efficiency of PS
beads as a chromatography matrix for epitope excision of
bPrP(25-241) was then tested with mAb3E7 immobilized,
using the very similar experimental conditions as in the
experiments with the sepharose matrix. A summary of the
bPrP(25-241) peptides identified in the supernatant and in
the elution fractions is shown in Figs. 4a, b, respectively.
The absolute peak intensities averaged over the elution time
of each of the bPrP(25-241) peptides are presented as
partial ESI–FTICR mass spectra. Only two specific
peptides [150–160] and [150–161] with overlapping
sequences were detected in the elution fraction. They
correspond to the mAb3E7 epitope which we have
determined earlier using the indirect approach based on
chemical cross-linking and mass spectrometry. A part of
this sequence, bPrP peptide [150–155], was also deduced
from the PEPSCAN method [26] as an epitope on bPrP
recognized by the mAb3E7. Therefore, our data are in
complete agreement with previously obtained results.
Conclusions
This study shows the advantages of using PS beads as an
affinity chromatography matrix when determining an
epitope on bPrP by limited proteolysis and mass spectro-
metric peptide mapping method (epitope excision). Non-
specific binding of bPrP molecules was not observed when
employing this column material. The usage of PS beads is a
better alternative to the sepharose matrix in the case of
proteins with a strong tendency to aggregate like bPrP or to
interact with carbohydrate matrices.
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